Aerosol Delivery TRIZ Cases

Lyophilized lipid structures hydrate into multilamellar vesicles, resolving low drug entrapment efficiency and complex manufacturing processes.

Lower strength imiquimod formulations reduce application site reactions while maintaining efficacy through periodic dosing regimens.

Photocrosslinked hybrid hydrogels merge polysaccharides with poly(ester amide) polymers to form unified biomedical materials.

A topical skin cream formulation uses Acalypha indica oil and Rosa damascena Mill oil to enhance bioavailability.

A foamed hydrophobic composition retains air bubbles to generate strong ultrasound echoes.

Strain-promoted azide-alkyne cycloaddition creates covalent hydrogel networks without metal catalysts, resolving biocompatibility issues from toxic byproducts.

A PEG-based hydrogel system forms through click polymerization between alkynoates and secondary amines.

A topical gel formulation delivers 2-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazinone derivatives directly to wound sites.

A topical emulsion containing corosolic, oleanolic, and ursolic acids treats skin lesions without invasive procedures.

A ferrogel sensor detects glucose levels by altering planar coil inductance through hydrogel swelling.

A syringe with a compressible porous matrix holds pharmaceuticals in soluble dry glass.

PLGA microspheres encapsulate SNAP to provide stable, sustained nitric oxide release, resolving low stability and side effects of gaseous donors.

Segmented hydrogel networks combine covalent and supramolecular bonds to resolve the trade-off between mechanical strength and reversibility.

Biocompatible catalysts accelerate hydrazone crosslink exchange for injectability, then diffuse away to restore network stability and cell viability.

Segmented applicator delivers probiotics and growth factors simultaneously to prevent premature activation and extend shelf life.

Purified herbal compounds inhibit inflammation and regulate immune responses, avoiding systemic side effects of corticosteroids.

Plant fats and DMSO improve bioavailability while eliminating emulsifiers that cause allergic reactions.

Zwitterionic hydrogel core-shell structures reduce foreign body reactions while enabling efficient nutrient exchange for implantable devices.

A flexible biodegradable gel carrier composed of polyol fatty acid ester and hydrogenated vegetable oil delivers stable drug release.

A conductive hydrogel combines PEDOT:PSS with PEG-linker-(BX)n oligopeptides to form a non-covalent assembly.

Condensing aminooxy and aldehyde groups forms oxime bonds, eliminating toxic metals and radicals that compromise protein activity.

Pressurized foamable antibiotic composition delivers balanced topical dosage via aerosol packaging assembly.

Gel-cream bases with humectants enhance transdermal absorption while reducing skin irritation and gastrointestinal side effects.

A monoglyceride composition forms a semi-occlusive film to promote wound healing.

Stable fenoldopam topical formulations enhance skin penetration using pH control and solubilizing agents.

PLGA-PEG-PLGA triblock copolymers form a gel at body temperature to provide sustained pain relief without compromising motor function.

A supramolecular alginate hydrogel encapsulates living cells and bioactive compounds to support long-term viability.

A Salvia plebia and Scutellariae radix compound cream enhances skin adhesion and active ingredient penetration through a specific oil-water emulsion matrix.

A covalently crosslinked polyampholyte matrix enhances mechanical stability for cell encapsulation applications.

A topical wound healing composition combines calcium channel blockers and vasodilators to accelerate tissue regeneration.

Isopropyl myristate and cetostearyl alcohol stabilize acyclovir and hydrocortisone emulsions against phase separation at 40°C.